Rivian Automotive, Inc.
RIVN · NASDAQ
Analyst ratings
buy · 20 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 14, 2026 | Morgan Stanley | Maintains | Underweight | $13.00 |
| July 9, 2026 | UBS | Maintains | Neutral | $17.00 |
| July 8, 2026 | BNP Paribas | Maintains | Outperform | $24.00 |
| July 7, 2026 | Jefferies | Maintains | Hold | $17.00 |
| June 10, 2026 | Needham | Reiterates | Buy | $23.00 |
| June 3, 2026 | TD Cowen | Reiterates | Buy | $20.00 |
| May 11, 2026 | DA Davidson | Maintains | Neutral | $15.00 |
| May 1, 2026 | BNP Paribas | Reiterates | Outperform | $22.00 |
| May 1, 2026 | Cantor Fitzgerald | Maintains | Neutral | $19.00 |
| May 1, 2026 | Benchmark | Reiterates | Buy | $25.00 |
| May 1, 2026 | Needham | Reiterates | Buy | $23.00 |
| April 10, 2026 | Tigress Financial | Maintains | Buy | $25.00 |
| April 6, 2026 | Canaccord Genuity | Maintains | Buy | $22.00 |
| April 1, 2026 | DA Davidson | Upgrades | Neutral | $14.00 |
| March 20, 2026 | Canaccord Genuity | Maintains | Buy | $22.00 |
| March 10, 2026 | TD Cowen | Upgrades | Buy | $20.00 |
| February 17, 2026 | Stifel | Maintains | Buy | $20.00 |
| February 17, 2026 | DA Davidson | Downgrades | Underperform | $14.00 |
| February 13, 2026 | UBS | Upgrades | Neutral | $16.00 |
| February 13, 2026 | TD Cowen | Maintains | Hold | $17.00 |
| February 13, 2026 | Wedbush | Reiterates | Outperform | $25.00 |
| February 13, 2026 | Piper Sandler | Maintains | Neutral | $18.00 |
| February 13, 2026 | Wells Fargo | Maintains | Equal-Weight | $15.00 |
| February 13, 2026 | Benchmark | Maintains | Buy | $25.00 |
| February 13, 2026 | Deutsche Bank | Upgrades | Buy | $23.00 |
| January 14, 2026 | UBS | Downgrades | Sell | $15.00 |
| January 8, 2026 | Piper Sandler | Maintains | Neutral | $20.00 |
| December 19, 2025 | Wedbush | Maintains | Outperform | $25.00 |
| December 18, 2025 | Baird | Upgrades | Outperform | $25.00 |
| December 12, 2025 | Goldman Sachs | Maintains | Neutral | $16.00 |
| December 12, 2025 | Needham | Maintains | Buy | $23.00 |
| December 8, 2025 | Morgan Stanley | Downgrades | Underweight | $12.00 |
| November 17, 2025 | Stifel | Maintains | Buy | $17.00 |
| November 14, 2025 | Tigress Financial | Maintains | Buy | $25.00 |
| November 11, 2025 | DA Davidson | Maintains | Neutral | $15.00 |
| November 5, 2025 | Goldman Sachs | Maintains | Neutral | $13.00 |
| October 20, 2025 | JP Morgan | Maintains | Underweight | $10.00 |
| October 20, 2025 | Mizuho | Downgrades | Underperform | $10.00 |
| October 6, 2025 | UBS | Maintains | Neutral | $13.00 |
| October 3, 2025 | Canaccord Genuity | Maintains | Buy | $21.00 |
| September 29, 2025 | Goldman Sachs | Maintains | Neutral | $15.00 |
| September 23, 2025 | Mizuho | Maintains | Neutral | $14.00 |
| August 25, 2025 | Needham | Reiterates | Buy | $14.00 |
R2 SUV launch and path to profitability
The R2 midsize SUV is viewed as a transformational catalyst capable of driving Rivian toward profitability by the end of the decade. Q2 2026 delivery beats and raised full-year guidance to 65,000–70,000 vehicles signal growing operational momentum, with the most optimistic analysts setting price targets as high as $25.
Rivian has already abandoned its 2027 profitability target, pushing positive EBITDA expectations to 2028 at the earliest. Negative automotive gross margins persisted into Q1 2026 at -$62 million, and management's own guidance projects adjusted EBITDA of -$1.8B to -$2.1B for full-year 2026, raising serious doubts about execution timelines.
Equity dilution and capital raise strategy
The $1.5B capital raise, while dilutive, strengthened Rivian's cash position to $5.3 billion and fulfills mandatory DOE loan equity contributions. This liquidity runway, supplemented by a $1 billion Volkswagen investment, provides the financial foundation needed to execute the R2 ramp-up and Georgia plant construction.
Rivian's $1.74B stock offering — timed immediately after a 19% rally — directly dilutes existing shareholders and triggered a 15% single-day share price collapse. With short interest at 13.26% and ongoing cash burn, repeated equity issuances raise structural concerns about the company's ability to self-fund operations.
Analyst conviction and valuation credibility
Following the Q2 delivery beat, analysts at Morgan Stanley, UBS, and BNP Paribas all raised their price targets, with BNP Paribas maintaining an Outperform rating and a $24 target. The stock carries a Buy consensus rating with an average price target of $20.47, reflecting confidence in Rivian's multi-year growth trajectory.
Analyst opinion on Rivian is deeply fractured, with price targets ranging from $9 to $25 and only 11 of 26 covering analysts rating it Buy or higher, while 5 rate it Sell or Strong Sell. Morgan Stanley maintains an Underweight rating with a $13 target, underscoring massive uncertainty around the company's production and financial timeline.